title: A case report of the new Polyzene™-F COBRA PzF™ Nanocoated Coronary Stent System (NCS): Addressing an unmet clinical need.
abstract: Because of anticipated antiplatelet medication risks, patients who are not DES candidates or who are at particularly high risk for bleeding events have been targeted initially for treatment with the COBRA PzF Coronary Stent System. We report the case of a successful experience with a new, Polyzene™-F COBRA PzF™ Coronary Stent System, designed to impart thrombo-resistance and reduce inflammation, to achieve shorter dual antiplatelet therapy duration while reducing restenosis incidence in a high risk patient with atrial fibrillation.
authors.affiliation: Heart Center at the Isar, Am Isarkanal 30, 81379 Munich, Germany.
authors.forename: Panorea
authors.initials: P
authors.lastname: Styllou
authors.affiliation: Heart Center at the Isar, Am Isarkanal 30, 81379 Munich, Germany. Electronic address: sigmund@silber.com.
authors.forename: Sigmund
authors.initials: S
authors.lastname: Silber
mesh_terms: D000368:Aged; D015906:Angioplasty, Balloon, Coronary / Q000295:instrumentation* / Q000379:methods; D001281:Atrial Fibrillation / Q000150:complications; D020099:Coated Materials, Biocompatible; D017023:Coronary Angiography; D023921:Coronary Stenosis / Q000150:complications / Q000000981:diagnostic imaging / Q000628:therapy*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D050997:Nanomedicine / Q000295:instrumentation* / Q000379:methods; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage; D011474:Prosthesis Design; D015607:Stents; D016896:Treatment Outcome
chemical_list: D020099:Coated Materials, Biocompatible; D010975:Platelet Aggregation Inhibitors
keywords: COBRA PzF Coronary Stent; Coronary stent; Percutaneous coronary intervention